new oral anticoagulants clinical trials
Clinical trials evaluating new oral anticoagulants are available for:
apixaban
(pdf version)
BMS 562247
BMS562247
BMS-562247
Eliquis
apixaban (without LMWH)
(pdf version)
BMS 562247
BMS562247
BMS-562247
Eliquis
apixaban 2.5mg
(pdf version)
BMS 562247
BMS562247
BMS-562247
Eliquis
aspirin
(pdf version)
aspirin + clopidogrel
(pdf version)
Plavix
Iscover
dabigatran
(pdf version)
Pradaxa
Pradax
dabigatran 110mg
(pdf version)
Pradaxa
Pradax
dabigatran 150mg
(pdf version)
Pradaxa
Pradax
dabigatran 220mg
(pdf version)
Pradaxa
Pradax
dabigatran 450mg
(pdf version)
Pradaxa
Pradax
edoxaban
(pdf version)
heparin/dabigatran
(pdf version)
Pradaxa
Pradax
heparin/edoxaban
(pdf version)
idraparinux
(pdf version)
idraparinux
idraparinux
(pdf version)
Crestor
otamixaban
(pdf version)
rivaroxaban
(pdf version)
Xarelto
BAY 59-7939
rivaroxaban (long duration)
(pdf version)
Xarelto
BAY 59-7939
rivaroxaban (without LMWH)
(pdf version)
Xarelto
BAY 59-7939
rivaroxaban 2.5mg
(pdf version)
Xarelto
BAY 59-7939
rivaroxaban 5mg
(pdf version)
Xarelto
BAY 59-7939
ximelagatran
(pdf version)
ximelagatran
xi-melagatran
Exanta
H 376 95
H 376-95
ximelagatran (without LMWH)
(pdf version)
ximelagatran
xi-melagatran
Exanta
H 376 95
H 376-95
Related topics:
Entry terms:
Antithrombins
dabigatran apixaban rivaroxaban
fondaparinux
NOAC NOACs
Search new oral anticoagulants clinical trials in
Pubmed
Search new oral anticoagulants clinical trials in
ClinicalTrials.gov
Search new oral anticoagulants clinical trials in
Wikipedia
Search new oral anticoagulants in
drugs.com
browse_trt2
|